CBD Delivery with the A-Synaptic GT4 Transdermal Delivery System in with Dravet Syndrome And/or Lennox-Gastaut Syndrome

Clinical trial NCT06738732 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06738732
Sponsor: Alexander Rotenberg
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lennox-Gastaut Syndrome (LGS)Dravet Syndrome (DS)

Start date: 2025-01-01
Primary completion: 2027-01-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.